#ILMN Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research
https://www.stocktitan.net/news/ILMN/illumina-introduces-the-first-distributed-whole-genome-sequencing-6xa9enmphnc2.html
Illumina (NASDAQ:ILMN) unveiled a distributed whole-genome sequencing MRD research solution, enabling labs to study molecular residual disease in solid tumors and blood cancers. The NovaSeq-compatible workflow delivers tumor fingerprinting and blood-based MRD detection in as fast as 5 days, with analytical sensitivity down to 10 ppm and a ctDNA algorithm showing 99.5% analytical specificity. Early access is available now, with global launch planned next year and an ultra-sensitive single-digit ppm duplex-based workflow in development.
